BioHealth News Archive

Baltimore’s MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations

Baltimore’s MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations

AI Simulation on MIRA1a Showcases Significant Potential Advantages Over Plant-Based Medical Marijuana Related to Anxiety, Appetite and Cognition BALTIMORE, Dec. 4, 2023 /PRNewswire/ -- MIRA Pharmaceuticals, Inc.…

Read More
ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs

ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs

The Biological and Emerging Infections Research Resources Program (BEI-RRP) contract, which merges the two programs, represents the fourth recompete award with NIAID since 2003.…

Read More
424 Capital Announces Investment in VaLogic

424 Capital Announces Investment in VaLogic

WAKEFIELD, Mass., Nov. 29, 2023 /PRNewswire/ -- 424 Capital announced today that it has completed a significant investment in VaLogic, a leading provider of GMP (Good…

Read More
citybiz Interviews Richard Hughen, CEO of Linshom Medical

citybiz Interviews Richard Hughen, CEO of Linshom Medical

Richard Hughen’s thirty years of professional medical device experience spans three Fortune 500 and four start-up companies with two successful exits to date. He…

Read More
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development

MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development

LEIDEN, the Netherlands, November 29, 2023 / B3C newswire / -- MIMETAS, a leader in human 3D disease modeling, and Yamaha Motor Co., Ltd., a…

Read More
REGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE® Trial

REGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE® Trial

ROCKVILLE, Md., Nov. 29, 2023 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that the first patient received RGX-202 at dose level 2 in the Phase I/II AFFINITY…

Read More
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

GAITHERSBURG, Md., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness…

Read More
Quroba Spotlights BHI Entrepreneur-in-Residence, Kwame Ulmer

Quroba Spotlights BHI Entrepreneur-in-Residence, Kwame Ulmer

BioHealth Innovation is thrilled to announce that our esteemed Entrepreneur-in-Residence, Kwame Ulmer, has been recognized by Quroba for his outstanding contributions to the MedTech…

Read More
TEDCO Invests in Baltimore Based NasaClip

TEDCO Invests in Baltimore Based NasaClip

COLUMBIA, Md. (November 27, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000 Social Impact Funds investment into NasaClip. “Nosebleeds…

Read More
End of Year 2023 Update: CarrTech Corp’s Notable Achievements and Future Endeavors

End of Year 2023 Update: CarrTech Corp’s Notable Achievements and Future Endeavors

As the year 2023 comes to a close, CarrTech Corp has demonstrated remarkable progress and innovation in the biotechnology and medical device sectors. The…

Read More
cultivate(MD) Capital Funds LP Announces Investment into Previous BHCR Crab Trap Winner, Nanochon

cultivate(MD) Capital Funds LP Announces Investment into Previous BHCR Crab Trap Winner, Nanochon

GRAND RAPIDS, Mich., Nov. 27, 2023 /PRNewswire/ -- cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced…

Read More
Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

BETHESDA, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced the closing of an underwritten…

Read More
Unveiling the Key to Healthcare Innovation Success: The NIH’s TABA Needs Assessment Report

Unveiling the Key to Healthcare Innovation Success: The NIH’s TABA Needs Assessment Report

Are you navigating the complex terrain of healthcare innovation? The National Institutes of Health (NIH) offers a powerful tool to guide your journey: the…

Read More
ChromaTan, Inc. Selected as a BLUE KNIGHT™ Company with laboratory space at JLABS @ Washington, DC

ChromaTan, Inc. Selected as a BLUE KNIGHT™ Company with laboratory space at JLABS @ Washington, DC

LOWER GWYNEDD, Penn.--(BUSINESS WIRE)--ChromaTan, Inc., a bioprocess development company revolutionizing the 123-year-old traditional batch biopurification process through transformational next-generation biomanufacturing solutions, announced today that…

Read More
President Biden Intends to Appoint Dr. W. Kimryn Rathmell as Director of the National Cancer Institute

President Biden Intends to Appoint Dr. W. Kimryn Rathmell as Director of the National Cancer Institute

Today, President Joe Biden announced his intent to appoint Dr. W. Kimryn Rathmell as the 17th Director of the National Cancer Institute (NCI), the federal…

Read More